Spine Conditions

Resource Center

FDA Alerts

Spinal Muscular Atrophy

FDA Approves Option for Spinal Muscular Atrophy

08/10/2020

The US Food and Drug Administration has approved an oral drug for the treatment of spinal muscular atrophy among patients aged 2 years or older.

08/10/2020

Research Summaries

Conference Coverage

Is There an Association Between Semaglutide Usage and Additional Surgical Interventions Following Transforaminal Lumbar Interbody Fusion?

05/22/2024

Anthony Calabro, MA

Researchers investigated semaglutide’s impact on weight-related muscle loss and its potential impact on spinal surgical outcomes, specifically transforaminal lumbar interbody fusion.

05/22/2024

Conference Coverage

Which Spinal Fusion Approach Provides a Lower Risk of Post-Surgical Complications For Elderly Patients With Cervical Trauma?

05/16/2024

Anthony Calabro, MA

Researchers examined in-hospital complications following anterior and posterior spinal fusion surgeries in elderly patients.

05/16/2024

Spine Conditions

Complications From LLIF Are Similar to Those From Other Spinal Procedures

06/28/2022

In a recent study, researchers examined the rate and type of complications associated with lateral lumbar interbody fusion during surgical reconstruction of the spine.

06/28/2022

Spinal Muscular Atrophy

FDA Approves Option for Spinal Muscular Atrophy

08/10/2020

The US Food and Drug Administration has approved an oral drug for the treatment of spinal muscular atrophy among patients aged 2 years or older.

08/10/2020

Spine Conditions

Surgery Improves Quality of Life in Vertebral Osteomyelitis

08/04/2020

There has been scant study of outcomes related to surgery among patients with vertebral osteomyelitis, though the condition often causes chronic pain and functional limitations. Researchers investigated...

08/04/2020

October 2024

Current Issue

October 2024

Volume 64

Issue 9